1. Home
  2. SEER vs ONCY Comparison

SEER vs ONCY Comparison

Compare SEER & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$2.23

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.89

Market Cap

113.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEER
ONCY
Founded
2017
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
113.4M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
SEER
ONCY
Price
$2.23
$0.89
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
206.8K
1.2M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
9.40
N/A
EPS
N/A
N/A
Revenue
$16,578,000.00
N/A
Revenue This Year
$2.14
N/A
Revenue Next Year
$25.90
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$1.55
$0.77
52 Week High
$2.41
$1.51

Technical Indicators

Market Signals
Indicator
SEER
ONCY
Relative Strength Index (RSI) 76.79 48.18
Support Level $2.15 $0.79
Resistance Level $2.38 $1.06
Average True Range (ATR) 0.06 0.06
MACD 0.03 -0.00
Stochastic Oscillator 86.72 37.00

Price Performance

Historical Comparison
SEER
ONCY

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: